Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Rutgers

Rutgers New Jersey Medical School Scientists Study How Worm Infections Can Weaken Immune Systems — And Life-Saving Vaccinations

New Brunswick, NJ, August 9, 2017 — Why are malaria, tuberculosis and hepatitis so prevalent in developing nations?  And why are most vaccines against these pathogens so ineffective?

Two Rutgers New Jersey Medical School scientists believe they may have found an answer in parasitic intestinal worms — which infect more than 1.5 billion people worldwide and can weaken the immune system’s ability to fend off disease, rendering vaccines less effective.

George Yap and William Gause received a $3 million grant from the National Institutes of Health this spring to study how worms prevent vaccinations from bolstering the immune system. Continue reading

RWJBarnabas’ Partnership with Rutgers Likely to Cost Other Medical Schools Their Student Slots

New Brunswick, NJ, August 2, 2017 — Anjalee Khemlani reports on NJBIZ that RWJBarnabas Health will likely be cutting ties with several universities as part of the new partnership with Rutgers University, NJBIZ has learned.

The health system will be prioritizing medical students from Rutgers for its available student slots, according to RWJBarnabas CEO Barry Ostrowsky.

“Our priority academic partner is Rutgers medical schools,” Ostrowsky said.  “The extent to which Rutgers needs teaching slots, our job is to make certain Rutgers … our system is able to meet its needs.  After that, if we have the ability to accommodate other relationships, we can maintain other relationships.” Continue reading

RWJBarnabas Health and Rutgers Announce Partnership Creating New Jersey’s Premier Academic Health Care System

New Brunswick, NJ, July 28, 2017 — RWJBarnabas Health and Rutgers University yesterday announced plans to partner and create the state’s largest academic health care system dedicated to providing high-quality patient care, leading-edge research and world-class health and medical education that will transform and advance health care in New Jersey.

Rutgers University President Robert Barchi, RWJBarnabas Health President and CEO Barry H. Ostrowsky and Rutgers Biomedical and Health Sciences Chancellor Brian Strom provided details of the new partnership outlined in a formal Letter of Intent during a ceremony at the Rutgers Cancer Institute of New Jersey in New Brunswick. Continue reading

Rutgers Researcher Receives $4.4 Million Investment to Develop Cancer Therapy

Dr. Scott Kachlany

New Brunswick, NJ, July 20, 2017 Scott Kachlany, Ph.D., a Rutgers School of Dental Medicine researcher, has received a $4.4 million commitment in venture capital to bring a potential therapy for cancer and autoimmune diseases closer to human clinical trials, he announced yesterday.

Dr. Kachlany’s company, Actinobac Biomed Inc., is slated for funding from the California-based Kairos Ventures, which will pay for the final stages of preclinical development before his therapeutic technology, called Leukothera, is tested on humans.

Leukothera is based on Kachlany’s discovery that an oral bacterium, which causes periodontal disease, can produce a protein that can be used to kill leukemia cells in animals. Continue reading

Interview: Dr. Debasish Dutta Becomes Chancellor at Rutgers-New Brunswick.

Dr. Debasish “Deba” Dutta

New Brunswick, NJ, July 6, 2017 — Debasish “Deba” Dutta, Ph.D., a respected academic and an experienced higher education administrator who has spearheaded innovation and strategic change at three top national research universities, became chancellor of Rutgers-New Brunswick on July 1.

Dr. Dutta also holds a faculty appointment and is a tenured distinguished professor of engineering.

Dr. Dutta came to Rutgers from Purdue University, where he was provost and executive vice president for academic affairs and diversity, with a faculty appointment as professor of mechanical engineering. Continue reading

Rutgers Research: Cloning Thousands of Genes for Massive Protein Libraries

New Brunswick, NJ, July 1, 2017 — Discovering the function of a gene requires cloning a DNA sequence and expressing it.  Until now, this was performed on a one-gene-at-a-time basis, causing a bottleneck.

Scientists at Rutgers University-New Brunswick in collaboration with Johns Hopkins University and Harvard Medical School have invented a technology to clone thousands of genes simultaneously and create massive libraries of proteins from DNA samples, potentially ushering in a new era of functional genomics. Continue reading

Rutgers Launches TechAdvance Funding Program to Advance Inventions Toward Commercialization

New Brunswick, NJ, June 29, 2017 — The Office of Research Commercialization (ORC) announces TechAdvance, a new fund created to advance Rutgers technologies toward commercialization.

The fund offers grants of up to $100,000 for promising technologies in areas including life science, physical science, engineering, agriculture and IT that have strong potential for commercial success but are “too early” for investors or industry partners. Continue reading

Rutgers-New Brunswick Rated One of Top 100 Research Universities in the World; Ranked No. 31 in U.S.

New Brunswick, NJ, June 26, 2017 — NJBIZ reported that Rutgers-New Brunswick was one of 37 universities in the United States to be ranked among the Top 100 research-intensive universities in the world, according to the prestigious CWTS Leiden Rankings.

Rutgers ranked No. 77 in the world, but No. 31 among schools based in the United States.

Rutgers was behind Cornell (No. 26), Washington University in St. Louis (27) and New York University (29). Continue reading

Rutgers Board of Governors Elects Sandy Stewart to Serve as Chair; Mark Angelson Vice Chair

Sandy J. Stewart

New Brunswick, NJ, June 19, 2017 — The Rutgers Board of Governors on June 15 selected two business leaders with strong ties to the university as the new leaders of the governing body.

Sandy J. Stewart, the current vice chair of the board and a highly respected biotech industry entrepreneur and scientist, was elected to serve as chair.

Mark A. Angelson, a 2014 gubernatorial appointee to the board, was elected to serve as board vice chair. He brings experience in law, business, government and international education. Continue reading

Rutgers Researchers Invent Lab-on-a-Chip Technology That Could Lead to Wearable Biosensors

Dr. Mehdi Javanmard

New Brunswick, NJ, June 15, 2017 — Imagine wearing a device that continuously analyzes your sweat or blood for different types of biomarkers, such as proteins that show you may have breast cancer or lung cancer.

Rutgers engineers have invented biosensor technology — known as a lab on a chip — that could be used in hand-held or wearable devices to monitor your health and exposure to dangerous bacteria, viruses and pollutants.

“This is really important in the context of personalized medicine or personalized health monitoring,” said Mehdi Javanmard, Ph.D., an assistant professor in the Department of Electrical and Computer Engineering at Rutgers University-New Brunswick. Continue reading